On 28 October 2021 this Extended ECHO session focused on neglected tropical disease laboratories, their potential to act as effective reference labs with effective implementation of robust quality management systems (QMS) including external quality assessment (EQA) programs. Presentations were made by Dr Andreas Gilsdorf, Head,....
LabCoP’s August 2021 ECHO session focused on sharing progress in HIV viral load (VL) monitoring among patients on antiretroviral therapy (ART) from eight sub-Saharan Africa countries between 2013 and 2018. Monitoring of VL suppression at individual and population level is necessary to ensure achievement of global epidemic contro....
On 15 July 2021 this Extended ECHO session was convened to discuss the WHO`s End TB Strategy that requires universal drug susceptibility testing and treatment of all tuberculosis case. Fewer than desired drug-resistant tuberculosis cases receive appropriate treatment due to either limited access to or sophisticated laboratory in....
On 29 April, 2021 this COVID-19 ECHO session was convened to discuss tuberculosis (TB) and the COVID-19 pandemic. This panel discussion session was moderated by Rinuka Garde, Senior Advisor at the Clinton Health Access Initiative, and included three renowned experts in the field of TB and general lung health, including: Lucica D....
On 8 April, 2021 this COVID-19 ECHO session was convened to discuss the Africa CDC Trusted Travel Platform and how to create a ‘Trusted Network’ of COVID-19 testing laboratories in Africa. To support the reopening of boarders and economies without risking disease spread, Africa CDC and partners are championing the concept of Tru....
On 17 March, 2021 this COVID-19 ECHO session was convened to discuss outcomes, successes and lessons from implementing emergency SARS-CoV-2 external quality assessment proficiency testing in Africa. The African Joint taskforce on Coronavirus (AFTCOR) guidance objective 2 under Laboratory diagnosis is to ensure quality-assured te....
On 18 February 2021, the LabCoP M&E Sub-Community of Practice held its second session that unpacked the fundamentals of monitoring and evaluation (M&E) and its importance in viral load (VL) monitoring. The use of VL data is essential for patient-level and program-level decision making. VL data is often unavailable, delayed, or u....
This module provides training and mentorship on infection prevention.
This module provides training and mentorship instruction on how to perform maternal resuscitation.
2.00 Hours
Victims of human trafficking (HT) often encounter health care providers (HCPs) while being trafficked, yet many HCPs lack adequate training regarding the issue. This module will provide an overview of HT, including common forms. Indicators of HT and vulnerabilities associated with HT will be reviewed. Health consequences victims....
This session gives an overview of the emergency and early management of seizures in adults and children, including the management of status epilepticus.
This session describes the types of localised trauma often seen after iatrogenic instrumentation of the peripheral vessels and chronic intravenous drug abuse. This includes complicated groin with bleeding, pseudoaneurysm formation with the potential for superinfection and mycotic aneurysm formation.
This advanced session looks at the properties of the main opioids used in the UK, when to switch opioids, particularly in renal impairment, and when to use subcutaneous opioid preparations.
In this lesson, we will explore the different types of long-acting injectable cabotegravir (CAB-LA) visits and scheduling for routine monitoring and follow-up activities.
In this lesson, we will review how to clinically manage long-acting injectable cabotegravir (CAB-LA) when the client returns after having missed a visit. This is in contrast to scenarios where a future visit needs to be postponed, covered in Lesson 8.
In this lesson, we will review how to use oral PrEP to postpone a future CAB-LA REINJECTION appointment. This is in contrast to a scenario where a client returns late after having already missed a visit, covered in Lesson 7.
In this lesson we will address how to translate technical clinical information about long-acting injectable cabotegravir (CAB-LA) into messages that clients can readily understand through counseling.
This session deals with the presentation and immediate management of the patient with sepsis. UKFP Curriculum 2021 This e-Learning session covers some of the behaviours in: • FPC 1: Clinical Assessment: Assess patient needs in a variety of clinical settings including acute, non-acute and community • FPC 2: Clinical Pri....
Insulin prescription and administration errors are a recurring problem within healthcare, yet are easily preventable. This session highlights the most common errors, and shows how to avoid them.
This session provides a framework for the drug and non-drug management of nausea and vomiting in end of life care. This session was reviewed by Saskie Dorman and Richard Kitchen and last updated in April 2019.
This session describes the pharmacological management of the patient with pre-existing hypertension and the current guidelines on hypertension before surgery.
This session examines the pharmacology of drugs that are used to induce hypotension and discusses appropriate drugs for described clinical situations.
This session describes some of the different mechanisms of interactions that can occur between drugs and some of the classification systems used to describe these interactions.
This session describes the ways in which drugs affect their action on the cells via transmembrane signalling.
The goal of this course is to provide the fundamental knowledge and technical skills needed to support the management of acutely hypoxic patients within a health facility. The content of the training focuses on the recognition and management of patients with mild to moderate respiratory distress and introduces frontline health w....